Parker Institute for Cancer Immunotherapy:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Parker Institute for Cancer Immunotherapy - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9390
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Parker Institute for Cancer Immunotherapy (Parker Institute), a subsidiary of The Parker Foundation is a nonprofit public benefit corporation which focuses on the development of immune therapies for the treatment of cancer. The institute coordinates together the scientists, nonprofits, academic institutions, biotechnology, and pharmaceutical industry partners to provide innovative services, tools and resources for new discoveries in cancer immunotherapy research. Its research focuses in the areas of T-cell therapies, tumor antigen discovery, tumor microenvironment and checkpoint blockade response. The institute works in collaboration with other research centers such as Memorial Sloan Kettering Cancer Center, Washington University School of Medicine, The University of Pennsylvania, Dana-Farber Cancer Institute, Stanford Medicine, and others. Parker Institute is headquartered in San Francisco, California, the US.

Parker Institute for Cancer Immunotherapy – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Parker Institute for Cancer Immunotherapy, Medical Devices Deals, 2012 to YTD 2018 9
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Tmunity Therapeutics Raises Additional USD35 Million in Series A Venture Financing 12
Tmunity Therapeutics Raises USD100 Million in Series A Venture Financing 14
ImaginAb Raises USD7.7 Million in Venture Financing 16
Partnerships 17
Parker Institute for Cancer Immunotherapy Enters into Partnership with Xyphos Biosciences 17
Inovio Pharma and Parker Institute for Cancer Immunotherapy Enter into Agreement 18
Seres Therapeutics to Enter into Partnership Agreement with MD Anderson and Parker Institute 19
Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Agreement 20
Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and Cancer Research Institute Enter into Research Partnership 21
Parker Institute for Cancer Immunotherapy Enters into Agreement with PsiOxus Therapeutics 22
Parker Institute for Cancer Immunotherapy – Key Employees 23
Parker Institute for Cancer Immunotherapy – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Government and Public Interest 25
May 15, 2018: Penn Study Finds that Different Diseases Elicit Distinct Sets of Exhausted T Cells 25
Product News 26
Apr 10, 2017: Parker Institute researchers publish first major scientific paper in Nature 26
Mar 07, 2018: Parker Institute for Cancer Immunotherapy: The battle to tame autoimmunity 27
Mar 05, 2018: Predicting Childhood Leukemia Relapse Using Machine Learning 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Key Facts 2
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Parker Institute for Cancer Immunotherapy, Deals By Therapy Area, 2012 to YTD 2018 8
Parker Institute for Cancer Immunotherapy, Medical Devices Deals, 2012 to YTD 2018 9
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tmunity Therapeutics Raises Additional USD35 Million in Series A Venture Financing 12
Tmunity Therapeutics Raises USD100 Million in Series A Venture Financing 14
ImaginAb Raises USD7.7 Million in Venture Financing 16
Parker Institute for Cancer Immunotherapy Enters into Partnership with Xyphos Biosciences 17
Inovio Pharma and Parker Institute for Cancer Immunotherapy Enter into Agreement 18
Seres Therapeutics to Enter into Partnership Agreement with MD Anderson and Parker Institute 19
Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Agreement 20
Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and Cancer Research Institute Enter into Research Partnership 21
Parker Institute for Cancer Immunotherapy Enters into Agreement with PsiOxus Therapeutics 22
Parker Institute for Cancer Immunotherapy, Key Employees 23

List of Figures
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Parker Institute for Cancer Immunotherapy, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Parker Institute for Cancer Immunotherapy:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Powerco Ltd:企業の戦略的SWOT分析
    Powerco Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CSC Steel Holdings Berhad:企業の戦略・SWOT・財務情報
    CSC Steel Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary CSC Steel Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Organogenesis Inc-医療機器分野:企業M&A・提携分析
    Summary Organogenesis Inc (Organogenesis) is a regenerative medicine company that operates in the areas of bioactive wound healing and soft tissue regeneration. The company’s products include apligraf and dermagraft. Its dermagraft is used for the treatment of full-thickness diabetic foot ulcers. Or …
  • Capitec Bank Holdings Limited (CPI):企業の財務・戦略的SWOT分析
    Capitec Bank Holdings Limited (CPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • China North Industries Corporation:企業の戦略・SWOT・財務情報
    China North Industries Corporation - Strategy, SWOT and Corporate Finance Report Summary China North Industries Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Nuclear Decommissioning Authority:企業の戦略的SWOT分析
    Nuclear Decommissioning Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Lepu Medical Technology (Beijing) Co Ltd (300003):医療機器:M&Aディール及び事業提携情報
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical technology company that offers medical equipments, pharmaceutical products and healthcare services. The company’s products include cardiovascular interventional products, surgical cardiology products, peripheral interventio …
  • Citizens Electric Corporation:発電所・企業SWOT分析
    Citizens Electric Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • China Suntien Green Energy Co Ltd (956):企業の財務・戦略的SWOT分析
    China Suntien Green Energy Co Ltd (956) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Northwest Territories Power Corp:企業の発電所・SWOT分析2018
    Northwest Territories Power Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • ING Life Insurance Company Korea, Ltd.:企業の戦略・SWOT・財務情報
    ING Life Insurance Company Korea, Ltd. - Strategy, SWOT and Corporate Finance Report Summary ING Life Insurance Company Korea, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • QuantuMDx Group Ltd:企業の製品パイプライン分析
    Summary QuantuMDx Group Ltd (QuantuMDx) is a developer of sciences tools and diagnostics products. The company’s products include Q-POC, a handheld DNA analyzer that provides an accurate molecular diagnostic results. It develops assays for diagnosis and drug susceptibility testing of infectious dise …
  • Page Industries Ltd:企業の戦略・SWOT・財務分析
    Page Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Page Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • National Institute on Drug Abuse:製薬・医療:M&Aディール及び事業提携情報
    Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine …
  • Safaricom Ltd
    Safaricom Ltd - Strategy, SWOT and Corporate Finance Report Summary Safaricom Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Inpex Corp (1605):企業の財務・戦略的SWOT分析
    Inpex Corp (1605) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Avalign Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Avalign Technologies Inc (Avalign), a subsidiary of Arlington Capital Partners, is a medical device company that supplies surgical implants, instruments, and delivery systems. The company offers precision machined instruments, cutting instruments, delivery systems, cases and trays, german sp …
  • Sumatec Resources Berhad (SUMATEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Sumatec Resources Berhad (Sumatec) is an oilfield service provider that offers of construction and drilling services to the oil and gas industry. The company’s services include engineering and construction for oil and gas facilities, oil and gas assets development, supply and management of o …
  • Shire Plc (SHP):製薬・医療:M&Aディール及び事業提携情報
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to treat patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆